Athersys
ATHX
$0.01350
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Operating Margin for Athersys (ATHX)
Operating Margin as of April 2024 (TTM): -1,576.98%
According to Athersys's latest financial reports and stock price the company's current Operating Margin is -1,576.98%. At the end of 2021 the company had an Operating Margin of -1,576.99%.
Operating Margin history for Athersys from 2007 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,576.99% | -71.33% |
| 2020 | -5,500.35% | 580.67% |
| 2019 | -808.08% | 689.91% |
| 2018 | -102.30% | -90.98% |
| 2017 | -1,134.05% | 1097.78% |
| 2016 | -94.68% | -40.77% |
| 2015 | -159.84% | -97.95% |
| 2014 | -7,809.44% | 91.79% |
| 2013 | -4,071.92% | 1939.41% |
| 2012 | -199.66% | 49.88% |
| 2011 | -133.22% | 3.45% |
| 2010 | -128.77% | -82.2% |
| 2009 | -723.25% | 17.62% |
| 2008 | -614.88% | -3.7% |
| 2007 | -638.50% | |
| 2005 | -381.51% | |
| 2003 | -1,566.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -101.45% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -102.19% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | -102.19% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -101.15% | 🇫🇷 France |
 Merck MRK | 27.73% | -101.76% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -101.22% | 🇺🇸 USA |
 Moderna
MRNA | 5.44% | -100.34% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.